Immunogenicity Evaluation of Subcutaneous Administration of Peptide Hydrolysate from Lolium Perenne (gpASIT+™) in Combination with Bacterial HSP70 (DnaK) in Patients with Seasonal Allergic Rhinitis: A Double Blind Placebo Controlled Trial

Immunogenicity Evaluation of Subcutaneous Administration of Peptide Hydrolysate from Lolium Perenne (gpASIT+™) in Combination with Bacterial HSP70 (DnaK) in Patients with Seasonal Allergic Rhinitis: A Double Blind Placebo Controlled Trial

Post-hoc analysis showed 4/9 patients who received low-dose gpASIT+(TM)/DnaK (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2015-02, Vol.135 (2), p.AB159-AB159
Hauptverfasser: Shamji, Mohamed H., PhD, FAAAAI, Ceuppens, Jan L., MD, PhD, Hellings, Peter W., MD, PhD, Durham, Stephen, MA, MD, FRCP, Duchateau, Jean, PhD, Parkin, Rebecca, BSc, Legon, Thierry, MBA, Pirotton, Sabine, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Bacteria
Lolium perenne
Peptides
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Post-hoc analysis showed 4/9 patients who received low-dose gpASIT+(TM)/DnaK (
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1459